| Identification | Back Directory | [Name]
Raltegravir potassium | [CAS]
871038-72-1 | [Synonyms]
MK 0518
Raltegravir K
Raltegravir-13C-d3
Raltegravir K salt
Raltegravir(MK-0518)
Raltegravir potassium
Raltegravir Potassium Salt
Raltegravir potassium, >=98%
Raltegravir PotassiumTablets
Potassium 4-((4-fluorobenzyl)carbamoyl)-1-methyl-2-(2-(5-methyl-1,3,4-oxadiazole-2-carboxamido
Potassium 4-[(4-fluorobenzyl)carbamoyl]-1-methyl-2[2-(2-methyl-1,3,4-oxadiazole-5-carboxamido)propan-2-yl]-6-oxo-1,6-dihydropyrimidin-5-olate
N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-4-pyrimidinecarboxamide Potassium Salt | [EINECS(EC#)]
682-461-3 | [Molecular Formula]
C20H20FN6O5.K | [MDL Number]
MFCD12031642 | [MOL File]
871038-72-1.mol | [Molecular Weight]
482.511 |
| Chemical Properties | Back Directory | [Appearance]
Off-White Solid | [Melting point ]
155-157°C | [storage temp. ]
-20°C Freezer | [solubility ]
DMSO (Slightly, Heated), Methanol (Slightly, Heated), Water (Slightly) | [form ]
Solid | [color ]
White to Light Beige | [CAS DataBase Reference]
871038-72-1 |
| Hazard Information | Back Directory | [Chemical Properties]
Off-White Solid | [Uses]
A potent human immunodeficiency virus (HIV) integrase inhibitor.A novel anti-AIDS drug | [in vivo]
Raltegravir induces viro-immunological improvement of nonhuman primates with progressing SIVmac251 infection. One non-human primate shows an undetectable viral load following Raltegravir monotherapy[5]. | [IC 50]
HIV-1; HIV-2 | [storage]
Store at -20°C |
|
|